ACADIAN ASSET MANAGEMENT LLC

Position in IMCR — Immunocore Holdings plc

CIK 916542 Boston, MA

Position in IMCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$15,107,893

-$922,226 QoQ

Shares Held

501,091

+8.5% QoQ

Ownership

0.985%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. IMCR ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc This page	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,107,893	501,091	+8.5%	Shares	Defined	2026-05-13
2025-12-31	$16,030,119	461,830	+131.5%	Shares	Defined	2026-02-10
2025-09-30	$7,247,726	199,497	+119.7%	Shares	Defined	2025-11-13
2025-06-30	$2,849,241	90,798	+392.3%	Shares	Defined	2025-08-07
2025-03-31	$547,203	18,443	-54.5%	Shares	Defined	2025-05-21
2024-12-31	$1,196,254	40,551	+4615.2%	Shares	Defined	2025-02-11
2024-09-30	$26,771	860	+14233.3%	Shares	Defined	2024-11-12
2023-06-30	$359	6	-100.0%	Shares	Defined	2023-08-07
2023-03-31	$3,137,610	63,463	-76.5%	Shares	Defined	2023-05-11
2022-12-31	$15,402,336	269,885	+46.3%	Shares	Defined	2023-02-14
2022-09-30	$8,658,787	184,465	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.